Diabetic Ketoacidosis

Overview

Journal Dis Mon

Specialty General Medicine

Date 2022 May 16

PMID 35577617

Authors

Angela Pauline P Calimag

Sylvia Chlebek

Edgar V Lerma

Joumana T Chaiban

Affiliations

Soon will be listed here.

Abstract

Diabetic ketoacidosis (DKA) is a form of a hyperglycemic emergency mainly characterized by the triad of hyperglycemia, ketosis, and anion gap metabolic acidosis. DKA may be the initial presentation in approximately 25-40 % of patients with type 1 diabetes. It may also occur in at least 34% of patients with type 2 diabetes. DKA has economic as well as medical implications. This review aims to explore and discuss diabetic ketoacidosis, its pathophysiology, clinical presentation, diagnosis, and management, including nuances in special populations such as pediatrics, obstetrics, and patients with chronic kidney disease.

Citing Articles

Adipose stromal cells increase insulin sensitivity and decrease liver gluconeogenesis in a mouse model of type 1 diabetes mellitus.

Lai H, Lee Y, Chen P, Tang C, Chen L Stem Cell Res Ther. 2025; 16(1):133.

PMID: 40069851 PMC: 11899698. DOI: 10.1186/s13287-025-04225-5.

Diabetic Ketoacidosis and the Use of New Hypoglycemic Groups: Real-World Evidence Utilizing the Food and Drug Administration Adverse Event Reporting System.

Thaibah H, Banji O, Banji D, Alshammari T Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006028 PMC: 11858861. DOI: 10.3390/ph18020214.

Altered association between cortisol and adrenocorticotropic hormone levels in the early stage of type 2 diabetic ketoacidosis.

Wang L, Meng X, Tang Y, Hao Y Front Endocrinol (Lausanne). 2025; 16:1418357.

PMID: 39959617 PMC: 11825314. DOI: 10.3389/fendo.2025.1418357.

Lymphocyte-C-reactive protein ratio upon admission to predict disease progression and ICU admission in adult patients with diabetic ketoacidosis.

Hu Y, Qiu S, Zhang J, Lai Q, Lin Y, Liu L Sci Rep. 2025; 15(1):3012.

PMID: 39849007 PMC: 11759335. DOI: 10.1038/s41598-024-84054-3.

Metabolomic signature of pediatric diabetic ketoacidosis: key metabolites, pathways, and panels linked to clinical variables.

Spagnolo P, Tweddell D, Cela E, Daley M, Clarson C, Rupar C Mol Med. 2024; 30(1):250.

PMID: 39707182 PMC: 11660668. DOI: 10.1186/s10020-024-01046-9.